[시장보고서]세계의 페니실린 시장 - 산업규모, 점유율, 동향, 기회 및 예측, 제품별, 유형별, 투여경로별, 최종사용자별, 지역별, 경쟁별(2020-2030년)

세계의 페니실린 시장 - 산업규모, 점유율, 동향, 기회 및 예측, 제품별, 유형별, 투여경로별, 최종사용자별, 지역별, 경쟁별(2020-2030년)

Penicillin Market - Global Industry Size, Share, Trends, Opportunity & Forecast, Segmented By Product, By Type, By Route of Administration, By End User, By Region & Competition, 2020-2030F

상품코드 : 1732856

리서치사 : TechSci Research

발행일 : 2025년 05월

페이지 정보 : 영문 180 Pages

라이선스 & 가격 (부가세 별도)

US $ 4,500

￦ 6,151,000

Unprintable PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 불가능하며, 텍스트의 Copy&Paste도 불가능합니다.

US $ 5,500

￦ 7,519,000

PDF and Excel (Multi-User License)

PDF 및 Excel 보고서를 기업의 팀이나 기관에서 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 및 Excel 이용 범위와 동일합니다.

US $ 8,000

￦ 10,936,000

PDF and Excel (Custom Research License)

PDF 및 Excel 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 및 Excel 이용 범위와 동일합니다. 80시간의 애널리스트 타임이 포함되어 있고 Copy & Paste 가능한 PPT 버전도 제공됩니다. 짧은 Bespoke 리서치 프로젝트 수행에 맞는 라이선스입니다.

ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.

한글목차

페니실린 세계 시장은 2024년에 101억 5,000만 달러로 평가되었으며, 2030년에는 125억 8,000만 달러에 이르고, CAGR 3.60%로 성장할 것으로 예측됩니다.

페니실린은 약 1세기 전에 발견되었음에도 불구하고, 그 폭넓은 스펙트럼 활성, 비용 효과, 영구적인 임상적 유용성에 의해 항균 치료의 요점으로 계속되고 있습니다. 신약과의 경쟁과 같은 장애물에 직면하고 있는 것, 특히 신흥국 지역에서의 헬스케어 인프라의 확대, 인구동태의 변화, 약제제제나 딜리버리 메커니즘의 지속적인 진보에 의해 지원되고 있습니다.

시장 개요
예측 기간	2026-2030년
시장 규모 : 2024년	101억 5,000만 달러
시장 규모 : 2030년	125억 8,000만 달러
CAGR : 2025-2030년	3.60%
급성장 부문	베타 락타마제 억제제
최대 시장	북미

시장 성장 촉진요인

세균 감염률 상승

주요 시장 과제

항생제 내성과 박테리아 균주의 진화

주요 시장 동향

드래그 제형 및 전달 방법의 혁신

시장 규모와 예측
- 금액별
시장 점유율 및 예측
- 제품별(벌크, 용량)
- 유형별(아미노페니실린, 항녹농균 페니실린, β락타마제 억제제, 기타)
- 투여경로(경구, 근육내, 정맥내)
- 최종사용자별(병원 및 클리닉, 제약 및 바이오테크놀러지 기업, 학술기관 및 연구기관)
- 지역별
- 기업별(2024년)
시장 맵

제6장 북미 페니실린 시장 전망

시장 규모와 예측
시장 점유율 및 예측
북미 : 국가별 분석
- 미국
- 캐나다
- 멕시코

제7장 유럽 페니실린 시장 전망

시장 규모와 예측
시장 점유율 및 예측
유럽 : 국가별 분석
- 독일
- 영국
- 이탈리아
- 프랑스
- 스페인

제8장 아시아태평양 페니실린 시장 전망

시장 규모와 예측
시장 점유율 및 예측
아시아태평양 : 국가별 분석
- 중국
- 인도
- 일본
- 한국
- 호주

제9장 남미 페니실린 시장 전망

시장 규모와 예측
시장 점유율 및 예측
남미 : 국가별 분석
- 브라질
- 아르헨티나
- 콜롬비아

제10장 중동 및 아프리카 페니실린 시장 전망

시장 규모와 예측
시장 점유율 및 예측
중동 및 아프리카 : 국가별 분석
- 남아프리카
- 사우디아라비아
- 아랍에미리트(UAE)

제11장 시장 역학

성장 촉진요인
과제

제12장 시장 동향과 발전

최근 동향
제품 출시
합병과 인수

제13장 세계의 페니실린 시장 : SWOT 분석

제14장 경쟁 구도

Astellas Pharma Inc.
Novartis International AG
GlaxoSmithKline plc
Pfizer Inc.
Merck Co. & Inc.
F.Hoffmann-La Roche Ltd.
Toyama Chemical Co., Ltd.
Sanofi Aventis SA
MiddleBrook Pharmaceuticals, Inc.
Gilead Sciences Inc.

제15장 전략적 제안

제16장 기업 소개와 면책사항

SHW

영문 목차

영문목차

The Global Penicillin Market was valued at USD 10.15 Billion in 2024 and is projected to reach USD 12.58 Billion by 2030, growing at a CAGR of 3.60%. Despite its discovery nearly a century ago, penicillin remains a cornerstone of antibacterial therapy due to its broad-spectrum activity, cost-effectiveness, and enduring clinical utility. Its demand continues to be strong worldwide, driven by its therapeutic efficacy and affordability, particularly in treating various bacterial infections. Although the market faces hurdles such as rising antimicrobial resistance and competition from newer drugs, it is bolstered by expanding healthcare infrastructure, especially in developing regions, demographic shifts, and continuous advancements in drug formulations and delivery mechanisms. These dynamics collectively support the long-term growth and strategic importance of penicillin in the global antibiotic landscape.

Market Overview
Forecast Period	2026-2030
Market Size 2024	USD 10.15 Billion
Market Size 2030	USD 12.58 Billion
CAGR 2025-2030	3.60%
Fastest Growing Segment	Beta-Lactamase Inhibitor
Largest Market	North America

Key Market Drivers

Rising Prevalence of Bacterial Infections

The increasing incidence of bacterial infections significantly propels the growth of the Global Penicillin Market. A recent global health review found that bacterial infections, excluding tuberculosis, accounted for 7.7 million deaths worldwide-13.6% of all deaths-underscoring the critical need for effective antibiotics. Penicillin remains a primary treatment for various infections including respiratory tract conditions like pneumonia and bronchitis, skin and soft tissue infections, UTIs, streptococcal and staphylococcal infections, and STDs such as syphilis. These infections are particularly widespread in low- and middle-income countries, where access to clean water, sanitation, and healthcare is limited. Given its effectiveness against many such pathogens, penicillin's demand continues to rise in alignment with global infection rates.

Key Market Challenges

Antibiotic Resistance and Evolving Bacterial Strains

The escalating issue of antibiotic resistance represents a major challenge to the penicillin market. Misuse and overuse of antibiotics have led to resistant strains like Penicillin-resistant Streptococcus pneumoniae and MRSA, reducing the drug's effectiveness. This has compelled healthcare professionals to opt for more advanced and often costlier antibiotics. In turn, this shift impacts penicillin's market share and has led to stricter regulatory measures and antibiotic stewardship programs aimed at curbing inappropriate prescriptions, thereby restraining market growth.

Key Market Trends

Innovation in Drug Formulations and Delivery Methods

The penicillin market is experiencing growth through advancements in drug formulations and delivery systems. Novel developments like extended-release injectables, child-friendly suspensions, and combination therapies are enhancing patient adherence, broadening clinical applications, and minimizing side effects. These innovations are critical in maintaining penicillin's relevance against rising resistance, improving therapeutic outcomes, and opening up new segments, including neonatal and elderly care, thus driving further market expansion.

Key Market Players

Astellas Pharma Inc.
Novartis International AG
GlaxoSmithKline plc
Pfizer Inc.
Merck Co. & Inc.
F.Hoffmann-La Roche Ltd.
Toyama Chemical Co., Ltd.
Sanofi Aventis SA
MiddleBrook Pharmaceuticals, Inc.
Gilead Sciences Inc

Report Scope:

In this report, the Global Penicillin Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Penicillin Market, By Product:

Bulk
Dosage

Penicillin Market, By Type:

Aminopenicillin
Antipseudomonal Penicillin
Beta Lactamase Inhibitor
Others

Penicillin Market, By Route of Administration:

Oral
Intramuscular
Intravenous

Penicillin Market, By End User:

Hospitals & Clinics
Pharmaceutical & Biotechnology Companies
Academic & Research Institutions

Penicillin Market, By Region:

North America
- United States
- Canada
- Mexico
Europe
- France
- United Kingdom
- Italy
- Germany
- Spain
Asia-Pacific
- China
- India
- Japan
- Australia
- South Korea
South America
- Brazil
- Argentina
- Colombia
Middle East & Africa
- South Africa
- Saudi Arabia
- UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Penicillin Market.

Available Customizations:

Global Penicillin market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

1. Product Overview

1.1. Market Definition
1.2. Scope of the Market
- 1.2.1. Markets Covered
- 1.2.2. Years Considered for Study
- 1.2.3. Key Market Segmentations

2. Research Methodology

2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations

3. Executive Summary

3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Penicillin Market Outlook

5.1. Market Size & Forecast
- 5.1.1. By Value
5.2. Market Share & Forecast
- 5.2.1. By Product (Bulk, Dosage)
- 5.2.2. By Type (Aminopenicillin, Antipseudomonal Penicillin, Beta Lactamase Inhibitor, Others)
- 5.2.3. By Route of Administration (Oral, Intramuscular, Intravenous)
- 5.2.4. By End User (Hospitals & Clinics, Pharmaceutical & Biotechnology Companies, Academic & Research Institutions)
- 5.2.5. By Region
- 5.2.6. By Company (2024)
5.3. Market Map

6. North America Penicillin Market Outlook

6.1. Market Size & Forecast
- 6.1.1. By Value
6.2. Market Share & Forecast
- 6.2.1. By Product
- 6.2.2. By Type
- 6.2.3. By Route of Administration
- 6.2.4. By End User
- 6.2.5. By Country
6.3. North America: Country Analysis
- 6.3.1. United States Penicillin Market Outlook
  - 6.3.1.1. Market Size & Forecast
    - 6.3.1.1.1. By Value
  - 6.3.1.2. Market Share & Forecast
    - 6.3.1.2.1. By Product
    - 6.3.1.2.2. By Type
    - 6.3.1.2.3. By Route of Administration
    - 6.3.1.2.4. By End User
- 6.3.2. Canada Penicillin Market Outlook
  - 6.3.2.1. Market Size & Forecast
    - 6.3.2.1.1. By Value
  - 6.3.2.2. Market Share & Forecast
    - 6.3.2.2.1. By Product
    - 6.3.2.2.2. By Type
    - 6.3.2.2.3. By Route of Administration
    - 6.3.2.2.4. By End User
- 6.3.3. Mexico Penicillin Market Outlook
  - 6.3.3.1. Market Size & Forecast
    - 6.3.3.1.1. By Value
  - 6.3.3.2. Market Share & Forecast
    - 6.3.3.2.1. By Product
    - 6.3.3.2.2. By Type
    - 6.3.3.2.3. By Route of Administration
    - 6.3.3.2.4. By End User

7. Europe Penicillin Market Outlook

7.1. Market Size & Forecast
- 7.1.1. By Value
7.2. Market Share & Forecast
- 7.2.1. By Product
- 7.2.2. By Type
- 7.2.3. By Route of Administration
- 7.2.4. By End User
- 7.2.5. By Country
7.3. Europe: Country Analysis
- 7.3.1. Germany Penicillin Market Outlook
  - 7.3.1.1. Market Size & Forecast
    - 7.3.1.1.1. By Value
  - 7.3.1.2. Market Share & Forecast
    - 7.3.1.2.1. By Product
    - 7.3.1.2.2. By Type
    - 7.3.1.2.3. By Route of Administration
    - 7.3.1.2.4. By End User
- 7.3.2. United Kingdom Penicillin Market Outlook
  - 7.3.2.1. Market Size & Forecast
    - 7.3.2.1.1. By Value
  - 7.3.2.2. Market Share & Forecast
    - 7.3.2.2.1. By Product
    - 7.3.2.2.2. By Type
    - 7.3.2.2.3. By Route of Administration
    - 7.3.2.2.4. By End User
- 7.3.3. Italy Penicillin Market Outlook
  - 7.3.3.1. Market Size & Forecast
    - 7.3.3.1.1. By Value
  - 7.3.3.2. Market Share & Forecast
    - 7.3.3.2.1. By Product
    - 7.3.3.2.2. By Type
    - 7.3.3.2.3. By Route of Administration
    - 7.3.3.2.4. By End User
- 7.3.4. France Penicillin Market Outlook
  - 7.3.4.1. Market Size & Forecast
    - 7.3.4.1.1. By Value
  - 7.3.4.2. Market Share & Forecast
    - 7.3.4.2.1. By Product
    - 7.3.4.2.2. By Type
    - 7.3.4.2.3. By Route of Administration
    - 7.3.4.2.4. By End User
- 7.3.5. Spain Penicillin Market Outlook
  - 7.3.5.1. Market Size & Forecast
    - 7.3.5.1.1. By Value
  - 7.3.5.2. Market Share & Forecast
    - 7.3.5.2.1. By Product
    - 7.3.5.2.2. By Type
    - 7.3.5.2.3. By Route of Administration
    - 7.3.5.2.4. By End User

8. Asia-Pacific Penicillin Market Outlook

8.1. Market Size & Forecast
- 8.1.1. By Value
8.2. Market Share & Forecast
- 8.2.1. By Product
- 8.2.2. By Type
- 8.2.3. By Route of Administration
- 8.2.4. By End User
- 8.2.5. By Country
8.3. Asia-Pacific: Country Analysis
- 8.3.1. China Penicillin Market Outlook
  - 8.3.1.1. Market Size & Forecast
    - 8.3.1.1.1. By Value
  - 8.3.1.2. Market Share & Forecast
    - 8.3.1.2.1. By Product
    - 8.3.1.2.2. By Type
    - 8.3.1.2.3. By Route of Administration
    - 8.3.1.2.4. By End User
- 8.3.2. India Penicillin Market Outlook
  - 8.3.2.1. Market Size & Forecast
    - 8.3.2.1.1. By Value
  - 8.3.2.2. Market Share & Forecast
    - 8.3.2.2.1. By Product
    - 8.3.2.2.2. By Type
    - 8.3.2.2.3. By Route of Administration
    - 8.3.2.2.4. By End User
- 8.3.3. Japan Penicillin Market Outlook
  - 8.3.3.1. Market Size & Forecast
    - 8.3.3.1.1. By Value
  - 8.3.3.2. Market Share & Forecast
    - 8.3.3.2.1. By Product
    - 8.3.3.2.2. By Type
    - 8.3.3.2.3. By Route of Administration
    - 8.3.3.2.4. By End User
- 8.3.4. South Korea Penicillin Market Outlook
  - 8.3.4.1. Market Size & Forecast
    - 8.3.4.1.1. By Value
  - 8.3.4.2. Market Share & Forecast
    - 8.3.4.2.1. By Product
    - 8.3.4.2.2. By Type
    - 8.3.4.2.3. By Route of Administration
    - 8.3.4.2.4. By End User
- 8.3.5. Australia Penicillin Market Outlook
  - 8.3.5.1. Market Size & Forecast
    - 8.3.5.1.1. By Value
  - 8.3.5.2. Market Share & Forecast
    - 8.3.5.2.1. By Product
    - 8.3.5.2.2. By Type
    - 8.3.5.2.3. By Route of Administration
    - 8.3.5.2.4. By End User

9. South America Penicillin Market Outlook

9.1. Market Size & Forecast
- 9.1.1. By Value
9.2. Market Share & Forecast
- 9.2.1. By Product
- 9.2.2. By Type
- 9.2.3. By Route of Administration
- 9.2.4. By End User
- 9.2.5. By Country
9.3. South America: Country Analysis
- 9.3.1. Brazil Penicillin Market Outlook
  - 9.3.1.1. Market Size & Forecast
    - 9.3.1.1.1. By Value
  - 9.3.1.2. Market Share & Forecast
    - 9.3.1.2.1. By Product
    - 9.3.1.2.2. By Type
    - 9.3.1.2.3. By Route of Administration
    - 9.3.1.2.4. By End User
- 9.3.2. Argentina Penicillin Market Outlook
  - 9.3.2.1. Market Size & Forecast
    - 9.3.2.1.1. By Value
  - 9.3.2.2. Market Share & Forecast
    - 9.3.2.2.1. By Product
    - 9.3.2.2.2. By Type
    - 9.3.2.2.3. By Route of Administration
    - 9.3.2.2.4. By End User
- 9.3.3. Colombia Penicillin Market Outlook
  - 9.3.3.1. Market Size & Forecast
    - 9.3.3.1.1. By Value
  - 9.3.3.2. Market Share & Forecast
    - 9.3.3.2.1. By Product
    - 9.3.3.2.2. By Type
    - 9.3.3.2.3. By Route of Administration
    - 9.3.3.2.4. By End User

10. Middle East and Africa Penicillin Market Outlook

10.1. Market Size & Forecast
- 10.1.1. By Value
10.2. Market Share & Forecast
- 10.2.1. By Product
- 10.2.2. By Type
- 10.2.3. By Route of Administration
- 10.2.4. By End User
- 10.2.5. By Country
10.3. MEA: Country Analysis
- 10.3.1. South Africa Penicillin Market Outlook
  - 10.3.1.1. Market Size & Forecast
    - 10.3.1.1.1. By Value
  - 10.3.1.2. Market Share & Forecast
    - 10.3.1.2.1. By Product
    - 10.3.1.2.2. By Type
    - 10.3.1.2.3. By Route of Administration
    - 10.3.1.2.4. By End User
- 10.3.2. Saudi Arabia Penicillin Market Outlook
  - 10.3.2.1. Market Size & Forecast
    - 10.3.2.1.1. By Value
  - 10.3.2.2. Market Share & Forecast
    - 10.3.2.2.1. By Product
    - 10.3.2.2.2. By Type
    - 10.3.2.2.3. By Route of Administration
    - 10.3.2.2.4. By End User
- 10.3.3. UAE Penicillin Market Outlook
  - 10.3.3.1. Market Size & Forecast
    - 10.3.3.1.1. By Value
  - 10.3.3.2. Market Share & Forecast
    - 10.3.3.2.1. By Product
    - 10.3.3.2.2. By Type
    - 10.3.3.2.3. By Route of Administration
    - 10.3.3.2.4. By End User

11. Market Dynamics

11.1. Drivers
11.2. Challenges

12. Market Trends & Developments

12.1. Recent Developments
12.2. Product Launches
12.3. Mergers & Acquisitions

13. Global Penicillin Market: SWOT Analysis

14. Competitive Landscape

14.1. Astellas Pharma Inc.
- 14.1.1. Business Overview
- 14.1.2. Product & Service Offerings
- 14.1.3. Recent Developments
- 14.1.4. Financials (If Listed)
- 14.1.5. Key Personnel
- 14.1.6. SWOT Analysis
14.2. Novartis International AG
14.3. GlaxoSmithKline plc
14.4. Pfizer Inc.
14.5. Merck Co. & Inc.
14.6. F.Hoffmann-La Roche Ltd.
14.7. Toyama Chemical Co., Ltd.
14.8. Sanofi Aventis SA
14.9. MiddleBrook Pharmaceuticals, Inc.
14.10.Gilead Sciences Inc.